CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 276 filers reported holding CUBIST PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $430,000 | -4.7% | 6,161 | 0.0% | 0.01% | 0.0% |
Q1 2014 | $451,000 | +4.4% | 6,161 | -1.8% | 0.01% | +11.1% |
Q4 2013 | $432,000 | +5.6% | 6,277 | -2.5% | 0.01% | -10.0% |
Q3 2013 | $409,000 | +103.5% | 6,440 | +55.0% | 0.01% | +100.0% |
Q2 2013 | $201,000 | – | 4,154 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,843,688 | $122,310,000 | 9.14% |
HealthCor Management, L.P. | 1,100,000 | $72,974,000 | 3.75% |
SECTOR GAMMA AS | 199,990 | $13,267,000 | 3.10% |
AMI ASSET MANAGEMENT CORP | 365,309 | $24,235,000 | 2.38% |
Redmile Group, LLC | 283,756 | $18,824,000 | 2.17% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 1,134,336 | $75,250,000 | 2.10% |
PointState Capital LP | 1,650,000 | $109,461,000 | 1.98% |
Tamarack Capital Management, LLC | 110,000 | $7,297,000 | 1.62% |
Tekla Capital Management LLC | 494,454 | $32,802,000 | 1.54% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 3,421,430 | $226,978,000 | 1.39% |